Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteri
Trang 1ALZHEIMER'S DISEASE 207
Hu,J., Miyatake, E, Aizu, Y, Nakagawa, H., Nakamura, S., Tamaoka, A., Takahash, R., Urakami,
~ , and Shoji, M (1999) Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population Neurosci Lett 277, 65-67
Hyman, B T., and Trojanowski, J Q (1997) Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment ofAlzheimer Disease.J Neuropathol Exp NeuroL 56, 1095-1097
Iraizoz, I., Guijarro,J L., Gonzalo, L M., and de Lacalle, S (1999) Neuropathological changes
in the nucleus basalis correlate with clinical measures of dementia Acta Neuropathol 98,
186-196
Irina, A., Seppo, H., Arto, M., Paavo, St., R., and Hilkka, S (1999) fl-Amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients Stroke
30, 613-618
Irizarry, M C., McNamara, M., Fedorchak, K., Hsiao, K., and Hyman, B T (1997a) APP-sw transgenic mice develop age-related A~ deposits and neuropil abnormalities, but no neu- ronal loss in CA1.J Neuropathol Exp Neurol 56, 965-973
Irizarry, M C., Soriano, E, McNamara, M., Fedorchak, K., Hsiao, K., and Hyman, B T (1997b) A/~ deposition is associated with neuropil changes, but not with overt neuronal loss in the
h u m a n amyloid precursor protein V717f (PDAPP) transgenic mouse.J Neurosa 17, 7053-
7059
lwata, N., Tsubuki, S., Takai, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y, and Saido, T C (2000) Identification of the major Afll-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition Nat Med 6, 143-150
iwatsubo, T., Saido, T C., Mann, D M A., Lee, V M.-Y, and Trojanowski,J Q (1996) Full-length amyloid-fl(1-42(43)) and amino-terminally modified and truncated amyloid-f142(43) de- posit in diffuse plaques Am.J Pathol 149, 1823-1830
Jack, C R., Petersen, R C., Xu, Y C., O'Brien, E C., Waring, S C., Tangalos, E G., Smith,
G E., Ivnik, R.J., Thibodeau, S N., and Kokmen, E (1998) Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease Ann Neurol 43, 303-310
Jellinger, K A., Bancher, C., and Fischer, E (1995) Interlaboratory comparison ofneuropathol- ogy assessment in Alzheimer's disease.J Neuropathol Exp Neurol 54, 129-130
Jorm, A E (1990) "The Epidemiology of Alzheimer's Disease and Related disorders." Chapman and Hall, London
Juottonen, K., Laakso, M P., Insausti, R., Lehtovirta, M., Pitk~men, A., Partanen, K., and Soininen, H (1998a) Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease Neurobiol Aging 19, 15-22
Juottonen, K~, Lehtovirta, M., Helisahni, S., Riekkinen, Sr., E J., and Soininen, H (1998b) Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's dis- ease carrying the apolipoprotein E epsilon4 allele J Neurol Neurosurg Psychiatry 65, 322-
327
Kalaria, R N (2000) The role of cerebral ischemia in Alzheimer's disease Neurobiol Aging
21, 321-330
Kalaria, R N., and Hedera, E (1995) Differential degeneration of the cerebral microvascula- ture in Alzheimer's disease Neuroreport 6, 477-480
Katzman, R (1993) Education and the prevalence of dementia and Alzheimer's disease
Neurology 43, 13-20
Katzman, R (1994) Apolipoprotein E and Alzheimer's disease Cu~ Opin Neurobiol 4, 703-
707
Trang 2Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Donnell Lingle, D., and Metter, E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study
of Aging Neurology 48, 1517-1521
Kaye, J A., Swihart, T., Howieson, D., Dame, A., Moore, M M., Karnos, T., Camicioli, R., Ball, M., Oken, B., and Sexton, G (1997) Volume loss of the hippocampus and temporal lobe
in healthy elderly persons destined to develop dementia Neurology 48, 1297-1304
Kehoe, E G., Russ, C., McIlory, S., Williams, H., Holmans, E, Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B., Liddell, M., Plomin, R., Dynan, K., Williams, N., Neal, J., Cairns, N.J., Wilcock, G., Passmore, E, Lovestone, S., Williams,J, and Owen, M.J (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease
Nat Genet 21, 71-72
Khachaturian, Z S (1985) Diagnosis of Alzheimer's disease Arch Neurol 42, 1097-1105
Khan, M A., Kushner, I., and Weitkamp, L R (1983) Genetics of HLA-associated disease: Rheumatoid arthritis Tissue Antigens 22, 182-185
Kokmen, E., Whisnant, J E, O'Fallon, W M., Chu, C E, and Beard, C M (1996) Dementia after ischaemic stroke: A population based study in Rochester, Minnesota, (1960-1984)
Neurology 46, 154-159
Kosaka, K., Yoshimura, M., Ikeda, K., and Budka, H (1984) Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying
d e g r e e - - a new disease? Clin Neuropathol 3, 185-192
Kosunen, O., Soininen, H., Paljarvi, L., Heinonen, O., Talasniemi, S., and Riekkinen, Sr.,
E J (1996) Diagnostic accuracy of Alzheimer's disease: a neuropathological study Acta Neu~vpathoL 91,185-193
Kril,J.J., and Halliday, G M (1999) Brain shrinkage in alcoholics: a decade on and what have
we learned? Prog~ Neurobiol 58, 381-387
Kril,J.J., Patel, S., Harding, A.J., and Halliday, G M (2000) Neuron loss in the hippocampus
in Alzheimer's disease is not solely as a result of tangle formation Brain Pathol 10, 787-
788
Kukall, W A., Larson, E B., Reifler, B V., Lampe, T H., Yerby, M., and Hughes, J (1990) Interrater reliability of Alzheimer's disease diagnosis Neurology 40, 257-260
Kuusisto,J., Koivisto, K., Mykkanen, L., Helkala, E L., Vanhanen, M., Hanninen, T., Kervinen, K., Kesaniemi, Y A., Riekkinen, EJ., and Laakso, M (1997) Association between features of the insulin resistence syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross sectional population based study Br Med.J 315, 1045-1049
Kwok,J B.J., Taddei, K., Hallupp, M., Fischer, C., Brooks, W S., Broe, G A., Hardy,J., Fulham, M.J., Nicholson, G A., Stell, R., St George-Hyslop, E H., Fraser, E E., Kakulas, B., Clarnette, R., Relkin, N., Gandy, S E., Schofield, E R., and Martins, R N (1997) Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease anmd preliminary evidence for association of presenilin-1 mutations with a novel phenotype Neuroreport 8,
1537-1542
Ladner, C.J., and Lee, J M (1998) Pharmacological drug treatment of Alzheimer's disease: The cholinergic hypothesis revisited J Neuropathol Exp Neurol 57, 719-731
Landen, M., Thorsell, A., Wallin, A., and Blennow, K (1996) The apolipoprotein E allele e4 does not correlate with the n u m b e r of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease J Neurol Neurosurg Psychiatry 61, 352-356
Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., and Wisniewski, H M (1995) Cell death in Alzheimer's disease evaluated by DNA fragmenta- tion in situ Acta Neuropathologica 89, 35-41
Trang 3ALZHEIMER'S DISEASE 2 0 9 Lee, M.-S., Kwon, Y T., Li, M., Peng,J., Friedlander, R M., and Tsai, L.-H (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 405, 360-364
Lehtovirta, M., Laakso, M E, Soininen, H., Helisalmi, S., Mannermaa, A., Helkala, E.-L., Partanen, K., Ryyn/men, M., Vainio, E, Hartikainen, P., and Riekkinen, Sr., P.J (1995) Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes Neuroscience 67, 65-72
Letenneur, L., Gilleron, V., Commenges, D., Helmer, C., Orgogozo, J M., and Dartigues, J E (1999) Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project.J Neurol Neurosurg Psychiatry 66, 177-
183
Leuba, G., and Kraftsik, R (1994) Visual cortex in Alzheimer's disease: occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks Neuro&'ol Aging
15, 29-43
Lin, B., Schmidt-Kastner, R., Busto, R., and Ginsberg, M D (1999) Progressive parenchymal deposition ofbeta-amyloid protein in rat brain following global ischaemia Acta Neuropathol
97, 359-368
Lopez, O L., Swihart, A A., Becker, J T., Reinmuth, O M., Reynolds, C E, Rezek, D L., and Daly, E L (1990) Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease Neurology 40, 1517-1522
Lu, D C., Rabizadeh, S., Chandra, S., Shayya, R E, Ellerby, L M., Ye, X., Salvesen, G S., Koo,
E H., and Bredesen, D E (2000) A second cytotoxic proteolytic peptide derived from amyloid t-protein precursor Nat Med 6, 397-404
Lu, K E, Hanes, S D., and Hunter, T (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis Nature 380, 544-547
Lu, E-J., Wulf, G., Zhou, X Z., Davies, E, and Lu, K E (1999) The prolyl isomerase Pinl restores the function ofAlzheimer-associated phosphorylated tau protein Nature 399, 784-
788
Lue, L.-E, Kuo, Y-M., Roher, A E., Brachova, L., Shen, Y, Sue, L., Beach, T., Kurth,J H., Rydel,
R E., and Rogers, J (1999) Soluble amyloid fl peptide concentration as a predictor of synaptic change in Alzheimer's disease Am J Pathol 155, 853-862
MacGowan, S H., Wilcock, G K., and Scott, M (1998) Effect of gender and apolipoprotein
E genotype on the response to anticholinesterase therapy in Alzheimer's disease Int ~L Ge~atr Psych 13, 625-630
Mackenzie, I R A., and Munoz, D G (1998) Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging Neurology 50, 986-990
Maki, E M., and Resnick, S M (2000) Longitudinal effects of estrogen replacement therapy
on PET cerebral blood flow and cognition Neurobiol Aging21, 373-383
Martin, E M., Wilson, R S., Penn, R D., Fox, J H., Clasen, R A., and Savoy, S M (1987) Cortical biopsy results in Alzheimer's disease: Correlation with cognitive deficits Neurology
37, 1201-1204
Matsumae, M., Kikinis, R., Morocz, I A., Lorenzo, A V., Sandor, T., Albert, M S., Black, E M., and Jolesz, E A (1996) Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging J Neurosurg 84, 982-991
Mattiace, L A., Davies, P., and Dickson, D W (1990) Detection of HLA-DR microglia in the
h u m a n brain is a function of both clinical and technical factors Am.J Pathol 136, 1101-
1114
McCulla, M M., Coats, M., van Fleet, N., Duchek, J., Grant, E., and Morris, J C (1989) Reliability of clinical nurse specialists in the staging of dementia Arch Neurol 46, 1210-
1211
Trang 4McGeer, P L., and McGeer, E G (1995) The inflammatory response system of brain: Impli-
cations for therapy of Alzheimer and other neurodegenerative diseases Brain Res Rev 21,
195-218
McGeer, P L., Schulzer, M., and McGeer, E G (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiological studies
Neurology 47, 425-432
McKee, A C., Kosik, K S., and Kowall, N W (1991) Neuritic pathology and dementia in
Alzheimer's disease Ann NeuroL 30, 156-165
McKeith, I G., Galasko, D., Kosaka, K., Perry, E., Dickson, D W., Hansen, L A., Salmon,
D P., Lowe, J., Mirra, S S., Byrne, E.J., Lennox, G., Quinn, N E, Edwardson, J A., Ince,
E G., Bergeron, C., Burns, A., Miller, B L., Lovestone, S., Collerton, D., Jansen, E N H., Ballard, C., de Vos, R A I., Wilcock, G K., Jellinger, K A., and Perry, R H (1996) Consensus guidelines for the clinical and pathologic diagnosis of Dementia with Lewy
Bodies (DLB): Report of the consortium on DLB international workshop Neurology 47,
1113-1124
McKeith, I G., Perry, E K., and Perry, R H (1999) Report of the second dementia with Lewy body international workshop Diagnosis and treatment Consortium on Dementia with
Lewy Bodies Neurology 53, 902-905
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E M (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group
u n d e r the auspices of the Department of Health and Human Services Taskforce on
Alzheimer's disease Neurology 34, 939-944
Middleton, D., Mawhinney, H., Curran, M D., Edwardson,J A., Perry, R., McKeith, I., Morris, C., Ince, E G., and Neill, D (1999a) Frequency of HLA-A and B alleles in early and
late-onset Alzheimer's disease Neurosci Lett 262, 140-142
Middleton, D., Vahidssr, D M., Savage, D A., Mawhinney, H., Curran, M D., and Passmore, E A (1999b) HLA-DR alleles are not associated with late-onset sporadic Alzheimer's disease
Alz Rep 2, 147-149
Miller, A K H., and Corsellis, J A N (1977) Evidence for a secular increase in h u m a n brain
weight during the past century Ann Human Biol 4, 253-257
Mirra, S S., Gearing, M., McKeel, D W., Crain, B.J., Hughes,J E, van Belle, G., and Heyman,
A (1994) Interlaboratory comparison of neuropathology assessments in Alzheimer's dis- ease: A study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
J Neuropathol Exp Neurol 53, 303-315
Mirra, S S., Heyman, A., McKeel, D., Sumi, S M., Crain, B J., Brownlee, L M., Vogel, E S., Hughes,J E, van Belle, G., and Berg, L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part II Standardisation of the neuropathologic assessment
of Alzheimer's disease Neurology 41,479-486
Mochizuki, A., Tamaoka, A., Shimohata, A., Komatsuzaki, Y, and Shoji, S (2000) Abeta42-
positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease Lancet
355, 42-43
Morris, C M., Benjamin, R., Leake, A., McArthur, E K., Candy, J M., Ince, E G., Tolwik, A., Bjertness, E., and Edwardson, J A (1995) Effect of apolipoprotein E genotype on
Alzheimer's disease neuropathology in a cohort of elderly Norwegians Neurosci Lett 201,
45-47
Morris, J c (1993) The Clinical Dementia Rating (CDR) : Current version and scoring rules
Neurology 43, 2412-2414
Morris,J C (1999) Is Alzheimer's disease inevitable with age? Lessons from clinicopathologic
studies of healthy aging and very mild Alzheimer's disease J Clin Invest 104, 1171-1173
Morris, J c., Heyman, A., Mohs, R C., Hughes, J P., van Belle, G., Fillenbaum, G., Mellits,
Trang 5ALZHEIMER'S DISEASE 2 1 1
E D., and Clark, C (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part I Clinical and neuropsychological assessment of Alzheimer's dis-
ease Neurology 39, 1159-1165
Morris,J C., McKeel, D W., Fulling, K., Torack, R M., and Berg, L (1988) Validation of clinical
diagnostic criteria for Alzheimer's disease Ann Neurol 14, 17-22
Morris,J C., Storandt, M., McKeel,Jr., D W., Rubin, E H., Price,J L., Grant, E A., and Berg,
L (1996) Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence
for presymptomatic and very mild Alzheimer's disease Neurology 46, 707-719
Morsch, R., Simon, W., and Coleman, E D (1999) Neurons may live for decades with neu-
rofibrillary tangles J NeuroL Neurosurg Psychiatry 58, 188-197
Mouton, E R., Martin, L.J., Calhoun, M E., Dal Forno, G., and Price, D L (1998) Cognitive
decline strongly correlates with cortical atrophy in Alzheimer's dementia Neurobiol Aging
19, 371-377
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., and McConlogue, L (2000) High-level neuronal expression of A/31-42 in wild-type h u m a n amyloid protein precursor transgenic mice:
Synaptotoxicity without plaque formation J Neurosci 20, 4050~t058
Mueller, E A., Moore, M M., Kerr, D C., Sexton, G., Camicioli, R M., Howieson, D B., Quinn,
J E, and Kaye,J A (1998) Brain volume preserved in healthy elderly through the eleventh
decade Neurology 51, 1555-1562
Mulnard, R A., Cotman, C W., Kawas, C., van Dyck, C H., Sano, M., Doody, R., Koss, E., Pfeiffer, E.,Jin, S., Gamst, A., Grundman, M., Thomas, R., and Thal, L.J (2000) Estrogen replacement therapy for treatment of nfild to moderate Alzheimer disease: A randomized
controlled trial Alzheimer's Disease Cooperative Study.J.A.M.A 283, 1007-1015
Munoz, D G., Ganapathy, G R., Eliasziw, M., and Hachinski, V (2000) Educational attainment
and socioeconomic status of patients with autopsy-confirmed Alzheimer disease Arch Neu-
rol 57, 85-89
Murphy, D G., DeCarli, C., McIntosh, A R., Daly, E., Mentis, M.J., Pietrini, E, Szczepanik, J., Schapiro, M B., Grady, C L., Horwitz, B., and Rapoport, S I (1996) Sex differences
in human brain morphometry and metabolism: An in vivo quantitative magnetic reso- nance imaging and positron emission tomography study on the effect of aging Arch Gen Psychiatry 53, 585-594
Nagy, Z., Esiri, M M., Hindley, N.J.,Joachim, C., Morris, J H., King, E M.-F., McDonald, B., Litchfield, S., Barnetson, L., Jobst, K A., and Smith, A D (1998) Accuracy of clinical eperational diagnostic criteria for Alzheimer's disease in relation to different pathological
diagnostic protocols Dement Geriatr Cogn Disord 9, 219-226
Nagy, Z., Esiri, M M.,Jobst, IL A.,Johnston, C., Litchfield, S., Sim, E., and Smith, A D (1995) Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary
tangle formation in Alzheimer's disease Neuroscience 69, 757-761
Nagy, Z., Esiri, M M., Jobst, K A., Morris, J H., King, E M.-E, McDonald, B., Joachim, C., Litchfield, S., Barnetson, L., and Smith, A D (1997a) The effects of additional pathology
on the cognitive deficit in Alzheimer disease.J Neuropathol Exp Neurol 56, 165-170
Nagy, Z., Hindley, N.J., Braak, H., Braak, E., Yilmazer-Hanke, D M., Schul~, C., Barnetson, L., King, E M.-E,Jobst, K A., and Smith, A D (1999) The progression of Alzheimer's disease from limbic regions to the neocortex: Clinical, radiological and pathological relationships
Dement Geriatr Cogn Disord 10, 115-120
Nagy, Z., Jobst, K A., Esiri, M M., Morris, J H., King, E M.-E, MacDonald, B., Litchfield, S., Barnetson, L., and Smith, A D (1996) Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: Clinicopathologic correlations
using three sets of pathologic diagnostic criteria Dementia 7, 76-81
Trang 6Nagy, Z., Vatter-Bittner, B., Braak, H., Braak, E., Yilmazer, D M., Schultz, C., and Hanke,
J (1997b) Staging of Alzheimer-type pathology: An interrater-intrarater study Dement Geriatr Cogn Disord 8, 248-251
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu,J., Yanker, B A., and Yuan,J (2000) Caspase-
12 mediates endoplasmic reticulum-specific apoptosis and cytotoxicity by amyloid-fl Nature
403, 98-103
Nathan, B P., Bellosta, S., Sanan, D A., Weisgraber, K H., Mahley, R W., and Pitas, R E (1994)
Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro Science264,
850-852
National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Diagnosis of Alzheimer's Disease (1997) Consensus recommen-
dations for the postmortem diagnosis of Alzheimer's disease Neurobiol Aging 18(4S),
S1-$3
Neill, D., Curran, M D., Middleton, D., Mawhinney, H., Edwardson,J A., McKeith, I., Ballard, C., Morris, C., Ince, E,Jaros, E., and Perry, R (1999) Risk for Alzheimer's disease in older
late-onset cases is associated with HLA-DRBI*3 Neurosci Lett 275, 137-140
Neve, R L., and Robakis, N K (1998) Alzheimer's disease: A re-examination of the amyloid
hypothesis Trends Neurosci 21, 15-19
Newell, K L., Hyman, B T., Growdon,J H., and Hedley-Whyte, T E (1999) Application of the National Institute on Aging (NIA) Reagan Institute criteria for the neuropathological
diagnosis ofAlzheimer disease.J Neuropathol Exp Nenrol 58, 1147-1155
Nijhawan, D., Honarpour, N., and Wang, X (2000) Apoptosis in neural development and
disease Annu Rev Neurosci 23, 73-87
Niki, E., and Nakano, M (1990) Estrogens as antioxidants Methods Enzymol 186, 330-333
Ohm, T G., Busch, C., and Bohl, J (1997) Unbiased estimation of neuronal numbers in the
h u m a n nucleus coeruleus during aging Nenrobiol Aging 18, 393-399
Ohm, T G., Muller, H., Braak, H., and Bohl, J (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary
changes Neuroscience 64, 209-217
Ott, A., Stolk, R P., van Harskamp, E, Pols, H A P., Hofman, A., and Breteler, M M B (1999)
Diabetes mellitus and the risk of dementia The Rotterdam Study Neurology 53, 1937-
1942
Overmyer, M., Helisalmi, S., Soininen, H., Laakso, M., Riekkinen, Sr., P., and Alafuzoff, I
(1999) Astrogliosis and the ApoE genotype Dement Geriatr Cogn Disord 10, 252-257
Paganini-Hill, A., and Henderson, V W (1994) Estrogen deficiency and risk of Alzheimer's
disease Am.J Epidemiol 140, 256-261
Paganini-Hill, A., and Henderson, V (1996) Estrogen replacement therapy and risk of
Alzheimer's disease Arch Intern Med 156, 2213-2217
Pakkenberg, B., and Gundersen, H J G (1997) Neocortical n e u r o n n u m b e r in humans:
Effects of sex and age.J Comp NeuroL 384, 312-320
Pantoni, L., Garcia, J H., and Brown, G G (1996) Vascular pathology in three cases of pro-
gressive cognitive deterioration.J Neurol Sci 135, 131-139
Patrick, G.N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, E, and Tsai, L.H (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Nature 402, 615-622
Payami, H., Schellenberg, G D., Zareparsi, S., Kaye,J., Sexton, G.J., Head, M A., Matsuyama,
S S.,Jarvik, L E, Miller, B., McManus, D Q., Bird, T D., Katzman, R., Heston, L., Norman, D., and Small, G W (1997) Evidence for an association of HLA-A2 allele with onset age
of Alzheimer's disease Neurology 49, 512-518
Pellegrini, L., Passer, B.J., Tabaton, M., Ganjei, J K., and D'Adamio, L (1999) Alternative,
Trang 7ALZHEIMER'S DISEASE 2 1 3
non-secretase processing of Alzheimer's fl-amyloid precursor protein during apoptosis by caspase-6 and-8.J Biol Chem 272, 21011-21016
Peruzzi, P., von Euw, D., and Lacombe, P (2000) Differentiated cerebrovascular effects of physostigmine and tacrine in cortical areas deafferented from the nucleus basalis magno- cellularis suggest involvement of basalocortical projections to microvessels Ann N Y Acad Sci 903, 394-406
Peters, A., Rosene, D L., Moss, M B., Kemper, T L., Abraham, C R., Tigges, J., and Albert,
M S (1996) Neurobiological bases of age-related cognitive decline in rhesus monkey
J Neuropathol Exp Neurol 55, 861-874
Poirier, J., Delisle, M.-C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Bertrand, P., Nalbantoglu, J., Gilfix, B M., and Gauthier, S (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease Proc Natl Acad Sci USA 92, 12260-12264
Price,J L., and Morris,J C (1999) Tangles and plaques in n o n d e m e n t e d aging and "Preclin- ical" Alzheimer's disease Ann Neurol 45, 358-368
Prince, M., Rabe-Hesketh, S., and Brennan, E (1998) Do antiarthritic drugs decrease the risk for cognitive decline? An analysis based on data from the MRC treatment trial of hypertension in older adults Neurology 50, 374-379
Ravens,] R (1978) Vascular changes in the h u m a n senile brain Adv Neurol 20, 487-501 Ray, W.J., Yao, M., Mumm, J., Schroeter, E H., Saftig, P., Wolfe, M., Selkoe, D.J., Kopan, R., and Goate, A M (1999) Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of Notch J Biol Chem 274, 36801-36807
Raz, N., Gunning, F M., Head, D., Dupuis, J H., McQuain, J., Briggs, S D., Loken, W J., Thornton, A E., and Acker, J D (1997) Selective aging of the h u m a n cerebral cortex observed in vivo: Differential vulnerability of the prefrontal gray matter Cereb Cortex 7, 268-282
Regeur, L (2000) Increasing loss of brain tissue with increasing dementia: A stereological study of post-mortem brains from elderly females Eur.J Neurol 7, 47-54
Regeur, L., Badsberg Jensen, G., Pakkenberg, H., Evans, S M., and Pakkenberg, B (1994)
No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type Neurobiol Aging 15, 347-352
Richard, E, Helbecque, N., Neuman, E., Guez, D., Levy, R., and Amouyel, E (1997) ApoE genotyping and response to drug treatment in Alzheimer's disease Lancet 349, 539 Risse, S C., Raskin, M A., Nochlin, D., Sumi, S M., Lampe, T H., Bird, T D., Cubberley, L., and Peskind, E R (1990) Neuropathological findings in patients with clinical diagnosis
of probable Alzheimer's disease Am J Psychiatry 147, 168-172
Rogers,J., Kirby, L C., Hempleman, S R., Berry, D L., McGeer, P L., Kaszniak, A W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, E, and Kogan, E (1993) Clinical trial of in- domethacin in Alzheimer's disease Neurology 43, 1609-1611
Roher, A E., Kuo, Y M., Potter, E E., Emmerling, M R., Durham, R A., Walker, D G., Sue, L I., Honer, W G., and Beach, T G (2000) Cortical cholinergic denervation elicits vascular A beta deposition Ann N.Y Acad Sci 903, 366-373
Roses, A D (1996) Apolipoprotein E in neurology C u ~ Opin Neurol 9, 265-270
Rozemuller, J M., van der Valk, E, and Eikelenboom, E (1992) Activated microglia and cere- bral amyloid deposits in Alzheimer's disease Res lmmunol 143, 646-649
Rubin, E H., Storandt, M., Miller, J E, Kinscherf, D A., Grant, E A., Morris,] C., and Berg,
L (1998) A prospective study of cognitive function and onset of dementia in cognitively healthy elders Arch Neurol 55, 395-401
Saunders, A M., Strittmatter, W.J., Schmechel, D., George-Hyslop, P H., Pericak-Vance, M A., Joo, S H., Rosi, B L., Gusella,J E, Crapper-MacLachlan, D R., Alberts, M.J., Hulette, C.,
Trang 8Crain, B., Goldgaber, D., and Roses, A D (1993) Association of apolipoprotein E allele
epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43,1467-1472
Scharf, S., Mander, A., Ugoni, A., Vajda, E, and Christophidis, N (1999) A double-blind
placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease Neurology 53,
197-201
Schenk, D B., Seubert, P., Lieberburg, I., and Wallace, J (2000) fl-peptide immunization
A possible new treatment for Alzheimer disease Arch Neurol 57, 934-936
Schmechel, D E., Saunders, A M., Strittmatter, W.J., Crain, B.J., Hulette, C M., Joo, S H., Pericak-Vance, M A., Goldgaber, D., and Roses, A D (1993) Increased amyloid beta- peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in
late-onset Alzheimer disease Proc Natl Acad Sci USA 90, 9649-9653
Schwab, C., Schulzer, M., Steele, J c., and McGeer, E L (1999) On the survival time of a tangled n e u r o n in the hippocampal CA4 region in parkinsonian dementia complex of
Guam Neurobiol Aging20, 57-63
Schwab, C., Steele,J C., and McGeer, E L (1998) Pyramidal neuron loss is matched by ghost
tangle increase in Guam parkinsonism-dementia hippocampus Acta Neuropathol 96, 409-
416
Selznick, L A., Holtzman, D M., Han, B H., Gokden, M., Srinivasan, A N., Johnson, Jr.,
E M., and Roth, K A (1999) In situ immunodetection of neuronal caspase-3 activation
in Alzheimer disease.J Neuropathol Exp Neurol 58, 1029-1026
Shear, E K., Sullivan, E V., Mathalon, D H., Lim, K O., Davis, L E, Yesavage,J A., Tinklenberg,
J R., and Pfefferbaum, A (1995) Longitudinal volumetric computed tomographic analysis
of regional brain changes in normal aging and Alzheimer's disease Arch NeuroL 52, 392-
402
Shefer, V E (1973) Absolute n u m b e r of neurons and thickness of the cerebral cortex during aging, senile and vascular dementia, and Pick's and Alzheimer's disease Zhurnal Nevropa-
tologii i Psikhiatrii imeni S S Korsakova 1972;72:1024-1029 (Translated in Neurosci Behav Physiol 6, 319-324.)
Shi, J., Perry, G., Smith, M A., and Friedland, R P (2000) Vascular abnormalitites: The insid-
ious pathogenesis of Alzheimer's disease Neurobiol Aging 21,357-361
Simic, G., Kostovic, I., Winblad, B., and Bogdanovic, N (1997) Volume and n u m b e r of neurons
of the h u m a n hippocampal formation in normal aging and Alzheimer's disease J Comp Neurol 379, 482-494
Skoog, I., Lernfelt, B., Landahl, S., Pahnertz, B., Andreasson, L.-A., Nilsson, L., Persson, G., Oden, A., and Svanborg, A (1996) 15-Year longitudinal study of blood pressure and
dementia Lancet 347, 1141-1145
Smale, G., Nichols, N R., Brady, D R., Finch, C E., and Horton,Jr., W E (1995) Evidence of
apoptotic cell death in Alzheimer's disease Exp Neurol 133, 225-230
Small, B.J., Fratiglioni, L., Viitanen, M., Winblad, B., and Backman, L (2000) The course of cognitive impairment in preclinical Alzheimer disease: Three- and 6-year follow-up of a
population-based sample Arch NeuroL 57, 839-844
Small, G W., Ebeling, S C., Matsuyama, S S., heyman, A., Reisner, E G., Renvoize, E B., and Sulkava, R (1991) Variable association of HLA-A2 in men with early-onset Alzheimer
disease Neurobiol Aging 12, 375-377
Smith, A D., and Jobst, K A (1996) Use of structural imaging to study the progression of
Alzheimer's disease Br Med Bull 52, 575-586
Smith, C D., Snowdon, D., and Markesbery, W R (2000) Periventricular white matter hyper-
intensities on MRI: Correlation with neuropathologic findings.J Neuroimaging 10, 13-16
Smith, M.J., Kwok, J B.J., McLean, C A., Kril, J.J., Broe, G A., Nicholson, G A., Cappai, R., Hallupp, M., Cotton, R G H., Masters, C L., Schofield, E R., and Brooks, W S (2001)
Trang 9ALZHEIMER'S DISEASE 2 1 5 Variable phenotype of Alzheimer's disease with spastic paraparesis in a pedigree with a deletion of exon 9 of the presenilin 1 gene Ann Neurol 49, 125-129
Snowdon, D A., Greiner, L H., Mortimer, J A., Riley, K P., Greiner, E A., and Markesbery,
W R (1997) Brain infarction and the clinical expression of Alzheimer's disease The Nun
study.J.A.M.A 277, 813-817
Sparks, D L (1997) Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease? Ann N.Y Acad Sci 826, 128-146
Sparks, D L., Hunsaker, J C., Scheff, S W., Kryscio, R.J., Henson,J L., and Markesbery, W R (1990) Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease
Neurobiol Aging 11, 601-607
St George-Hyslop, E H (2000) Molecular genetics of Alzheimer's disease Biol Psychiatry 47, 183-199
Stadelmann, C., Deckwerth, T L., Srinivasan, A., Bancher, C., Bruck, W., Jellinger, K., and Lassmann, H (1999) Activation of caspase-3 in single neurons and autophagic granules
of granulovacuolar degeneration in Alzheimer's disease Evidence for apoptotic cell death
Am J Pathol 155, 1459-1466
Stastny, P., Ball, E.J., Khan, M A., Olsen, N.J., Pincus, T., and Gao, X (1988) HLA-DR4 and other genetic markers in rheumatoid arthritis Br J Rheumatol 27 (Suppl 2), 132-138 Stern, Y., Gurland, B., Tatemichi, T., Tang, M., Wilder, D., and Mayeaux, R (1994) Influence
of education and occupation on the in cidence of Alzheimer's disease J.A.M.A 271, 1004-
1010
Stevens, M., van Du!jn, C M., de Knijff, P., van Broeckhoven, C., Heutink, E, Oostra, B A., Niermeijer, M E, and van Swieten, J C (1997) Apolipoprotein E gene and sporadic frontal lobe dementia Neurology 48, 1526-1529
Stewart, W E, Kawas, C., Corrada, M., and Metter, E.J (1997) Risk of Alzheimer's disease and duration of NSAID use Neurology 48, 626-632
Storey, E., and Cappai, R (1999) The amyloid precursor protein of Alzheimer's disease and the A~ peptide Neuropathol Appl Neurobiol 25, 81-97
Strittmatter, W.J., and Roses, A D (1995) Apolipoprotein E and Alzheimer disease Proc Natl Acad Sci USA 92, 4725-4727
Strittmatter, W.J., Weisgraber, K H., Huang, D Y., Dong, L M., Salvesen, G S., Pericak-Vance, M., Schmechel, D., Saunders, A M., Goldgaber, D., and Roses, A D (1993) Binding
of h u m a n apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease Proc Natl Acad Sci USA 90, 8098-
8102
Tapiola, T., Pirttila, T., Mikkonen, M., Mehta, E D., Alafuzoff, I., Koivisto, K., and Soininen, H (2000) Three-year follow-up of cerebrospinal fluid tan, beta-amyloid 42 and 40 concen- trations in Alzheimer's disease Neurosci Lett 280, 119-122
Terry, R D., de Theresa, R., and Hansen, L A (1987) Neocortical cell counts in normal h u m a n adult aging Ann Neurol 21,530-539
Thal, D R., Arendt, T., Waldmann, G., Holzer, M., Zedlick, D., Rub, U., and Schober, R (1998) Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology Neurobiol Aging 19, 517-525 Tierney, M C., Fisher, R H., Lewis, A J., Zorzitto, M L., Snow, W G., Reid, D W., and Nieuwstraten, P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathological study of 57 cases Neu-
rology 38, 359-364
Tohgi, H., Takahashi, S., Kato, E., Homma, A., Niina, R., Sasaki, K., Yonezawa, H., and Sasaki, M (1997) Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E e4 allele Neurosci Lett 236, 21-24
Trang 10Tolnay, M., and Probst, A (1999) Review: Tau protein pathology in Alzheimer's disease and
related disorders Neuropathol Appl Neurobiol 25, 171-187
Tong, X K., and Hamel, E (1999) Regional cholinergic denervation of cortical microvessels
and nitric oxide synthase-containing neurons in Alzheimer's disease Neuroscience 92, 163-
175
Turner, R S., Suzuki, N., Chyung, A S C., Younkin, S G., and Lee, V M Y (1996) Amyloids beta(40) and beta(42) are generated intracellularly in cultured h u m a n neurons and their
secretion increases with maturation J Biol Chem 271, 8966 8970
Unger, J., van Belle, G., and Heyman, A (1999) Cross-sectional vs longitudinal estimates of
cognitive change in the non-demented elderly: A CERAD study.J Am G~ Soc 47, 559-563 Uterman, G (1994) The apolipoprotein E connection Cu~ BioL 4, 362-365
Verkkoniemi, A., Somer, M., Rinne,J O., Myllykangas, L., Crook, R., Hardy, J., Viitanen, M., Kalimo, H., and Haltia, M (2000) Variant Alzheimer's disease with spastic paraparesis:
Clinical characterization Neurology 54, 1103-1109
Vincent, B., and Smith, J D (2000) Effect of estradiol on neuronal Swedish-mutated beta-
amyloid precursor protein metabolism: Reversal by astrocytic cells Biochem Bi~phys Res Commun 271, 82-85
Visser, P.J., Scheltens, E, Verhey, E R.J., Schmand, B., Launer, L.J.,Jolles, J., andJonker, C (1999) Medial temporal lobe atrophy and memory dysfunction as predictors for dementia
in subjects with mild cognitive impairment.J Neurol 246, 477-485
Vogels, O J M , Broere, C A J., Lak, H J T , Donkelaar, H J T., Nieuwenhuys, R., and Schultz, E M (1990) Cell loss and shrinkage in the nucleus basalis of Meynert complex
in Alzheimer's disease Neurobiol Aging 11, 3-13
Wahlund, L.-O., Julin, P., Lannfelt, L., Lindqvist, J., and Svensson, L (1999) Inheritance of
the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients Dement Geriatr Cogn Disord 10, 262-268
Walker, D G (1998) Inflammatory markers in chronic neurodegenerative disorders with
emphasis on Alzheimer's disease In "Neuroinflammation: Mechanisms and Management"
(P L Wood, ed.), pp 61-90 Humana Press, Totowa, NJ
Wang, J., Dickson, D W., Trojanowski, J Q., and Lee, V M.-Y (1999) The levels of soluble versus insoluble brain Aft distinguish Alzheimer's disease from normal and pathologic
aging Exp Neurol 158, 328-337
Weldon, D T., Rogers, S D., Ghilardi, J R., Finke, M E, Cleary, J P., O'Hare, E., Esler,
W E, Maggio, J E., and Mantyh, E W (1998) Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population
of neurons in the rat CNS in vivo.J Neurosci 18, 2161-2173
West, K M (1978) "Epidemiology of Diabetes and Its Vascular Complications." Elsevier, New York
West, M.J (1993) Regionally specific loss of neurons in the aging h u m a n hippocampus
Neurobiol Aging 14, 287-293
West, M.J., Coleman, E D., Flood, D G., and Troncoso,J C (1994) Differences in the pattern
of hippocampal neuronal loss in normal ageing and Alzheimer's disease Lancet 344, 769-
772
West, M.J., and Gundersen, H J G (1990) Unbiased stereological estimation of the n u m b e r
of neurons in the h u m a n hippocampus J Comp Neurol 296, 1-22
Wilson, C A., Doms, R W., and Lee, V M.-Y (1999) Intracellular APP processing and Aft
production in Alzheimer's disease J Neuropathol Exp Neurol 58, 787-794
Wolfe, M S., De Los Angeles, J., Miller, D D., Xia, W., and Selkoe, D.J (1999) Are prese- nilins intramembrane-cleaving proteases? Implications for the molecular mechanism of
Alzheimer's disease Biochemistry 38, 11223-11230